Literature DB >> 33842220

Sex differences in outcomes following less-invasive left ventricular assist device implantation.

Silvia Mariani1,2, Tong Li1, Karl Bounader1, Dietmar Boethig1, Alexandra Schöde1, Jasmin S Hanke1, Jana Michaelis1, L Christian Napp3, Dominik Berliner3, Guenes Dogan1, Roberto Lorusso2, Axel Haverich1, Jan D Schmitto1.   

Abstract

BACKGROUND: Worse outcomes in women compared to men undergoing left ventricular assist device (LVAD) implantation remain an underestimated problem in heart failure (HF) patients. With device miniaturization, less-invasive LVAD implantation techniques have gained relevance, but their impact on outcomes in women is unknown. This study investigates sex-related differences in patients undergoing LVAD implantation through less-invasive procedures.
METHODS: This retrospective single-center cohort study included patients who underwent isolated LVAD implantation between 2011 and 2018 through less-invasive techniques. Propensity score matching (PSM) was utilized to balance preoperative heterogeneity. Primary endpoint was two-year survival, and secondary endpoints included long-term survival, surgical outcomes and postoperative adverse events.
RESULTS: Baseline analysis of 191 patients (females 18.3%) showed differences in terms of age [female (median, 52; IQR, 47-61); male (median, 58.5; IQR, 49-66); P=0.005], underlying diagnosis (P<0.001), INTERMACS profile (P=0.009), history of previous cardiac surgery (P=0.049) and preoperative creatinine values [female (median, 110; IQR, 71-146); male (median, 126; IQR, 9-168); P=0.049]. Over a follow-up of 460.68 patient-years, Kaplan-Meyer analysis showed better survival in females (P=0.027) and a similar probability of cardiac transplantation (P=0.288). After PSM, females showed higher needs for intraoperative fresh frozen plasma (P=0.044) and platelets (P=0.001) but comparable postoperative outcomes. No sex-related differences were noticed regarding two-year outcomes, long-term survival and adverse events. LVAD-related infections remained the most common complication with males experiencing more pump infections than women (P=0.050).
CONCLUSIONS: Patients receiving less-invasive LVAD implantation do not show significant sex-related differences in short and long-term outcomes and survival. Prospective studies are needed to evaluate the role of less-invasive techniques in reducing sex-based disparities after LVAD implantation. 2021 Annals of Cardiothoracic Surgery. All rights reserved.

Entities:  

Keywords:  Left ventricular assist device (LVAD); lateral thoracotomy; minimally invasive surgery; sex differences

Year:  2021        PMID: 33842220      PMCID: PMC8033266          DOI: 10.21037/acs-2020-cfmcs-21

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  46 in total

1.  Is it Possible to Implant HeartMate 3 Less Invasively? New Pump, New Approach.

Authors:  Sinan Sabit Kocabeyoglu; Umit Kervan; Dogan Emre Sert; Ertekin Utku Unal; Burcu Demirkan; Yesim Guray; Emre Aygun; Osman Fehmi Beyazal; Mehmet Karahan; Mustafa Pac
Journal:  Artif Organs       Date:  2018-11-04       Impact factor: 3.094

2.  Sex-Specific Outcome Disparities in Patients Receiving Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-analysis.

Authors:  Vanessa Blumer; Rodrigo Mendirichaga; Gabriel A Hernandez; Gerardo Zablah; Sandra V Chaparro
Journal:  ASAIO J       Date:  2018 Jul/Aug       Impact factor: 2.872

3.  Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.

Authors:  Daniel Zimpfer; Arnt E Fiane; Robert Larbalestier; Steven Tsui; Paul Jansz; Andre Simon; Stephan Schueler; Martin Strueber; Jan D Schmitto
Journal:  Circ Heart Fail       Date:  2020-03-13       Impact factor: 8.790

4.  Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy.

Authors:  Jan D Schmitto; Ulrich Molitoris; Axel Haverich; Martin Strueber
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-07       Impact factor: 5.209

5.  Should women receive left ventricular assist device support?: findings from INTERMACS.

Authors:  Eileen M Hsich; David C Naftel; Susan L Myers; Eiran Z Gorodeski; Kathleen L Grady; Darlene Schmuhl; Karen L Ulisney; James B Young
Journal:  Circ Heart Fail       Date:  2012-01-18       Impact factor: 8.790

6.  Anesthetic Management for Left Ventricular Assist Device Implantation Through Left Thoracotomy: Evaluation of On-Pump Versus Off-Pump.

Authors:  C Sahutoglu; E Turksal; U Bilic; S Kocabas; F Zekiye Askar; P Ozturk; S Ertugay; C Engin; T Yagdi; M Ozbaran
Journal:  Transplant Proc       Date:  2017-04       Impact factor: 1.066

7.  Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.

Authors:  Abdelrahman Ahmed; Oluwole Adegbala; Emmanuel Akintoye; Chakradhari Inampudi; Mustafa Ajam; Ahmed S Yassin; Emmanuel Olawusi; Mohamed Shokr; Paulino Alvarez; Alexandros Briasoulis
Journal:  Ann Thorac Surg       Date:  2019-08-31       Impact factor: 4.330

8.  Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation.

Authors:  Roberta C Bogaev; Salpy V Pamboukian; Stephanie A Moore; Leway Chen; Ranjit John; Andrew J Boyle; Kartik S Sundareswaran; David J Farrar; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2011-01-22       Impact factor: 10.247

9.  Outcomes of Patients Implanted Using a Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump.

Authors:  Bantayehu Sileshi; Brian K O'Hara; Mary E Davis; Nicholas A Haglund; Xu Meng; Robert Deegan; John M Stulak; Sudhir S Kushwaha; Andrew Shaw; Simon Maltais
Journal:  ASAIO J       Date:  2016 Sep-Oct       Impact factor: 2.872

10.  Cost of Thoracotomy Approach: An Analysis of the LATERAL Trial.

Authors:  Nahush A Mokadam; Edwin McGee; Georg Wieselthaler; Duc Thinh Pham; Stephen H Bailey; G Victor Pretorius; Theodore J Boeve; Eleni Ismyrloglou; Martin Strueber
Journal:  Ann Thorac Surg       Date:  2020-03-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.